Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematologic malignancy characterized by the overexpression of CD123 and CD303 surface antigens. The gene discussed is IL3RA; the disease is CD4+/CD56+ hematodermic neoplasm.